Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PATISIRAN vs VUTRISIRAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PATISIRAN vs VUTRISIRAN: Safety Overview

Metric PATISIRAN VUTRISIRAN
Total FAERS Reports 2,708 1,425
Deaths Reported 384 321
Death Rate 14.2% 22.5%
Hospitalizations 1,050 550
Average Patient Age 65.6 yrs 72.2 yrs
% Female Patients 34.2% 31.3%
FDA Approval Date Aug 10, 2018 Jun 13, 2022
Manufacturer Alnylam Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc.
Route INTRAVENOUS SUBCUTANEOUS
Marketing Status Prescription Prescription